Article
NASP/SPAARx merger creates one, unified voice representing the fastest growing segments in the pharmacy and health care industries.
NASP/SPAARx merger creates one, unified voice representing the fastest growing segments in the pharmacy and health care industries.
The National Association of Specialty Pharmacy (NASP) and the Specialty Pharmacy Association of America (SPAARx) announced today the merger of the two organizations, creating the largest professional and trade association focused on the unique needs in specialty pharmacy.
“Merging the two organizations allows us to combine our leadership and focus on providing services for professionals and other stakeholders that will support the future of our industry,” Lawrence Irene, CEO of Armada, the founder of SPAARx, said. “This opportunity benefits everyone in our industry, allowing us to shine a spotlight on the increasingly important role specialty plays in health care.”
The new association is built on a core mission of providing advanced training in specialty and offering opportunities to build collaboration with the goal of improving patient outcomes. The leadership, representing thought leaders from all major stakeholders including specialty pharmacies, payers, manufacturers, group purchasing organizations and others, initially focuses their attention on building a dynamic strategic plan to address challenges and build opportunities in the specialty market.
“This is a historic moment in our industry—one in which our two organizations come together, recognizing the unique strengths each has contributed to specialty pharmacy and the pharmacy industry as a whole, to develop a strong, unified voice representing all specialty stakeholders,” Gary M. Cohen, BSPharm, RPh, CSP, NASP CEO said.
NASP and SPAARx will integrate their current Board of Directors, committees and members to develop a broad membership and volunteer-based association poised to lead in the pharmacy industry.
Visit www.nasprx.org to learn more.
SOURCE: NASP
FDA Approves Bimekizumab-Bkzx as Treatment for Hidradenitis Suppurativa